Nihon Chouzai Co Ltd (Nihon Chouzai) is a healthcare group that operates in various sectors of the medical industry. Its primary activities include operating a Dispensing Pharmacy, Pharmaceutical Manufacturing and Sales, Medical Professional Staffing and Placement, and Information Provision and Consulting.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Nihon Chouzai’s R&D arm focuses on innovation and investment in research and development (R&D) to maintain its competitive advantage in the pharmaceutical industry. It has consistently allocated resources to enhance product offerings and improve operational efficiency, with a particular emphasis on developing new pharmaceutical products and refining existing formulations to meet the changing needs of the healthcare market. Nihon Chouzai aims to increase the ratio of in-house manufactured products, which contributes to improved product quality and cost efficiency. By prioritizing R&D, the company is positioned to introduce solutions that comply with market demands and regulatory standards, thereby strengthening its product portfolio and reinforcing its standing within the pharmaceutical sector. In FY2025, R&D expenses amounted to JPY3,133 million, reflecting a 13.3% increase from FY2024.